ANDA 215566

COREPHARMA

FDA Drug Application

Application #215566

Application Sponsors

ANDA 215566

COREPHARMA

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET;ORAL	3.75MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM
002	TABLET;ORAL	7.5MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM
003	TABLET;ORAL	15MG	0	CLORAZEPATE DIPOTASSIUM	CLORAZEPATE DIPOTASSIUM

FDA Submissions

UNKNOWN;

ORIG

1

AP

2022-06-14

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

Accessdata Error

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215566
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)